BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 18, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 2, 2003
View Archived Issues
Novel inhibitors of MMP-12 and other metalloproteinases identified at AstraZeneca
Read More
Asahi Kasei presents new beta3-adrenoceptor agonists in recent patent
Read More
Imidazolinone-based p38 kinase inhibitors in early development at Tanabe Seiyaku
Read More
Shionogi describes novel NR1/NR2B-selective NMDA antagonists
Read More
Novel antiobesity agents in Bayer development pipeline
Read More
New analgesic COX-1 inhibitors prepared and tested by Fujisawa team
Read More
Novel MMP, TACE and/or aggrecanase inhibitors and their use reported by BMS scientists
Read More
Dual alpha4beta1/alpha4beta7 integrin antagonist profiled at ATS meeting
Read More
Potential new asthma therapeutic acts by neutralizing IL-13
Read More
Vaccine for specifically neutralizing IL-13 for use in asthma developed at GSK
Read More
SD-208 inhibits lung fibrosis induced by TGF-beta1 overexpression in rats
Read More
Inhibition of lung inflammation reported for the macrolide Z-104657A in rats
Read More
TAS-203 more effective than cilomilast in airways inflammation
Read More
Merck discontinues development of two diabetes projects
Read More
Launch of Clarinex RediTabs
Read More
Multiferon use expanded in Mexico
Read More
PTI-901 significantly improves common symptoms of IBS
Read More
Phase II efficacy data reported for intranasal apomorphine in FSD
Read More
No evidence of carcinogenicity in NexACT rat study
Read More
New phase II trial evaluates ISIS-14803 in HCV
Read More
Enrollment under way in pivotal Pompe's disease study of Myozyme
Read More
Microbially produced antiplatelet agent identified by Japanese group
Read More
Estrone derivatives with potent inhibitory activity against steroid sulfatase
Read More
IL-9-neutralizing antibody effective in mouse model of asthma
Read More
Allos plans NDA submission for RSR-13 for brain metastases from breast cancer
Read More
New phase II trial of Triapine and gemcitabine in pancreatic cancer
Read More
NCX-4016 does not negatively interact with COX-2 inhibitor in the stomach
Read More
Echelon receives NIH grant to further cancer research
Read More
